The forecast for re-import of penicillins or streptomycins in dosage forms into France indicates a gradual increase from 21.81 thousand kilograms in 2024 to 24.43 thousand kilograms in 2028. This represents a steady annual year-on-year growth—nearly 3% annually—pointing towards a consistent rise in demand or need for these antibiotics.
Future trends to watch for include potential shifts in healthcare policies impacting imports, changes in global antibiotic use or production, or developments in medical technologies, which may alter France’s re-importation needs. Additionally, monitoring changes in international trade agreements or collaborations in the pharmaceutical sector will be pertinent.
